Screening for sleep disordered breathing among children hospitalized for asthma exacerbation

BackgroundSleep disordered breathing (SDB) may exacerbate asthma and is a treatable comorbidity.ObjectiveTo design and implement a screening process for SDB in patients hospitalized for asthma exacerbation using quality improvement (QI) methods. We sought to improve screening for SDB from zero to 60...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatric pulmonology 2023-12, Vol.58 (12), p.3458-3465
Hauptverfasser: Gurbani, Neepa, Schuler, Christine L., Ignatiuk, Daniel, Albrecht, Jennifer, Guo, Yuping, Waits, Amanda, Kercsmar, Carolyn M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:BackgroundSleep disordered breathing (SDB) may exacerbate asthma and is a treatable comorbidity.ObjectiveTo design and implement a screening process for SDB in patients hospitalized for asthma exacerbation using quality improvement (QI) methods. We sought to improve screening for SDB from zero to 60% from July 2019 to December 2020.Design/MethodsA multidisciplinary team used QI methods to screen for SDB using the Michigan pediatric sleep questionnaire (PSQ) in patients 2−18 years hospitalized for asthma exacerbation. Key interventions included: pairing the PSQ screen with another element of routine care (the asthma risk factor screen), educating staff and physicians, engaging respiratory therapists to complete the PSQ and document scores, and modifying the electronic medical record (asthma order set and flowsheet for PSQ score documentation). A run chart tracked progress and descriptive statistics were generated.ResultsThere were 2067 patients admitted for asthma exacerbation during this project. The PSQ was completed for 1531 patients (74%) overall. Of screened patients, 360 (24%) had a positive PSQ; the mean age was 8.6 years. Approximately 14 months after the project began, ~90% of children admitted for asthma were being screened; subsequently, >80% of patients were being screened until May 2022. Screening with the PSQ occurred approximately 90% of the time when routine asthma risk screens were completed.ConclusionA screening process for SDB was successfully implemented and appeared feasible and sustainable. The high proportion of positive screens reinforces the importance of evaluating for SDB in the high‐risk population of children requiring hospitalization for asthma exacerbation.
ISSN:8755-6863
1099-0496
DOI:10.1002/ppul.26676